ISTA PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - February 25, 2011

Attached files

file filename
10-K - ISTA PHARMACEUTICALS, INC. FORM 10-K - ISTA PHARMACEUTICALS INCd10k.htm
EX-31.2 - CERTIFICATION OF CFO - SECTION 302 - ISTA PHARMACEUTICALS INCdex312.htm
EX-31.1 - CERTIFICATION OF CEO - SECTION 302 - ISTA PHARMACEUTICALS INCdex311.htm
EX-32.2 - CERTIFICATION OF CFO - SECTION 906 - ISTA PHARMACEUTICALS INCdex322.htm
EX-32.1 - CERTIFICATION OF CEO - SECTION 906 - ISTA PHARMACEUTICALS INCdex321.htm
EX-10.40 - AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT - ISTA PHARMACEUTICALS INCdex1040.htm
EX-10.10 - FIRST AMENDMENT TO LEASE DATED OCTOBER 21, 2010 - ISTA PHARMACEUTICALS INCdex1010.htm
EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ISTA PHARMACEUTICALS INCdex232.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements of ISTA Pharmaceuticals, Inc.:

 

  (1) Registration Statement (Form S-3 No. 333-82726),

 

  (2) Registration Statement (Form S-3 No. 333-90994),

 

  (3) Registration Statement (Form S-3 No. 333-101120),

 

  (4) Registration Statement (Form S-3 No. 333-103820),

 

  (5) Registration Statement (Form S-3 No. 333-114815),

 

  (6) Registration Statement (Form S-3 No. 333-135799),

 

  (7) Registration Statement (Form S-3 No. 333-144344),

 

  (8) Registration Statement (Form S-3 No. 333-144345),

 

  (9) Registration Statement (Form S-3 No. 333-154713),

 

  (10) Registration Statement (Form S-3 No. 333-155187),

 

  (11) Registration Statements (Form S-8 Nos. 333-56042),

 

  (12) Registration Statements (Form S-8 No.333-103281),

 

  (13) Registration Statements (Form S-8 No 333-103276),

 

  (14) Registration Statements (Form S-8 No 333-103279),

 

  (15) Registration Statements (Form S-8 No 333-104434),

 

  (16) Registration Statements (Form S-8 No 333-119910),

 

  (17) Registration Statements (Form S-8 No 333-123026),

 

  (18) Registration Statements (Form S-8 No 333-129036),

 

  (19) Registration Statements (Form S-8 No 333-131793),

 

  (20) Registration Statements (Form S-8 No 333-138204),

 

  (21) Registration Statements (Form S-8 No 333-140577),

 

  (22) Registration Statements (Form S-8 No 333-149621),

 

  (23) Registration Statements (Form S-8 No 333-160348),

 

  (24) Registration Statements (Form S-8 No 333-164357),

 

  (25) Registration Statements (Form S-8 No 333-164358),

of our reports dated February 25, 2011, related to the consolidated financial statements and consolidated financial statement schedule and the effectiveness of ISTA Pharmaceuticals, Inc.’s internal control over financial reporting, included in this Annual Report (Form 10-K) of ISTA Pharmaceuticals, Inc. for the year ended December 31, 2010.

 

/s/ BDO USA LLP

Costa Mesa, California

February 25, 2011

Stock widget

Investing forum

ISTA PHARMACEUTICALS INC Reports